GENNEX LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of GENNEX LABORATORIES have increased by 59.03% YoY .
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 7.50 % YoY. |
||
GENNEX LABORATORIES Last 5 Annual Financial Results
[BOM: 531739]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹138 Cr | ₹87 Cr | ₹66 Cr | ₹61 Cr | ₹60 Cr |
| Expenses | ₹121 Cr | ₹70 Cr | ₹61 Cr | ₹56 Cr | ₹53 Cr |
| Operating Profit (Excl OI) | ₹17 Cr | ₹17 Cr | ₹4.69 Cr | ₹5.38 Cr | ₹6.53 Cr |
| Other Income | ₹10 Cr | ₹4.91 Cr | ₹3.95 Cr | ₹1.38 Cr | ₹0.52 Cr |
| Interest | ₹3.61 Cr | ₹3.08 Cr | ₹1.35 Cr | ₹0.88 Cr | ₹0.74 Cr |
| Depreciation | ₹1.99 Cr | ₹2.37 Cr | ₹0.92 Cr | ₹0.79 Cr | ₹0.88 Cr |
| Profit Before Tax | ₹21 Cr | ₹16 Cr | ₹6.37 Cr | ₹5.09 Cr | ₹5.06 Cr |
| Profit After Tax | ₹18 Cr | ₹13 Cr | ₹4.92 Cr | ₹3.92 Cr | ₹4.04 Cr |
| Consolidated Net Profit | ₹18 Cr | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr |
| Earnings Per Share (Rs) | ₹0.86 | ₹0.80 | ₹0.50 | ₹0.35 | ₹0.32 |
| PAT Margin (%) | 10.65 | 11.60 | 13.40 | 6.85 | 6.01 |
| ROE(%) | 10.40 | 10.49 | 10.77 | 7.95 | 9.39 |
| ROCE(%) | 10.70 | 12.49 | 13.64 | 10.19 | 11.82 |
| Total Debt/Equity(x) | 0.36 | 0.13 | 0.12 | 0.22 | 0.23 |
Key Financials |
||
| Market Cap | : | ₹ 208.7 Cr |
| Revenue (TTM) | : | ₹ 183.1 Cr |
| Net Profit(TTM) | : | ₹ 20.6 Cr |
| EPS (TTM) | : | ₹ 0.8 |
| P/E (TTM) | : | 10.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENNEX LABORATORIES | -4.2% | -16.8% | -38% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -6.5% | 3.8% |
| DIVIS LABORATORIES | -0.2% | -5.5% | 35.7% |
| TORRENT PHARMACEUTICALS | 0.4% | -8.2% | 25.2% |
| CIPLA | 1.7% | -2% | -15.3% |
| DR REDDYS LABORATORIES | 4.9% | 7.7% | -2.5% |
| MANKIND PHARMA | 2.2% | -6.5% | -10.5% |
| LUPIN | -0.2% | -7.1% | -0.7% |
| ZYDUS LIFESCIENCES | 4.1% | -1% | 14.2% |
GENNEX LABORATORIES Revenues
[BOM: 531739]
| Y-o-Y | 59.03 % |
| 5 Yr CAGR | 23.31 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹138 Cr | 59.03 | |
| Mar2025 | ₹87 Cr | 32.18 | |
| Mar2024 | ₹66 Cr | 7.17 | |
| Mar2023 | ₹61 Cr | 2.62 | |
| Mar2022 | ₹60 Cr | - | |
GENNEX LABORATORIES Operating Profit
[BOM: 531739]
| Y-o-Y | -1.97 % |
| 5 Yr CAGR | 26.44 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 Cr | -1.97 | |
| Mar2025 | ₹17 Cr | 262.88 | |
| Mar2024 | ₹4.69 Cr | -12.74 | |
| Mar2023 | ₹5.38 Cr | -17.68 | |
| Mar2022 | ₹6.53 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -38.34 % |
| 5 Yr CAGR | 2.55 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 12.11% | -38.34 | |
| Mar2025 | 19.64% | 174.69 | |
| Mar2024 | 7.15% | -18.66 | |
| Mar2023 | 8.79% | -19.73 | |
| Mar2022 | 10.95% | - | |
GENNEX LABORATORIES Profit After Tax
[BOM: 531739]
| Y-o-Y | 59.35 % |
| 5 Yr CAGR | 45.55 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | 59.35 | |
| Mar2025 | ₹11 Cr | 83.61 | |
| Mar2024 | ₹6.19 Cr | 50.89 | |
| Mar2023 | ₹4.11 Cr | 1.66 | |
| Mar2022 | ₹4.04 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -8.19 % |
| 5 Yr CAGR | 15.38 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 10.65 % | -8.19 | |
| Mar2025 | 11.6 % | -13.43 | |
| Mar2024 | 13.4 % | 95.62 | |
| Mar2023 | 6.85 % | 13.98 | |
| Mar2022 | 6.01 % | - | |
GENNEX LABORATORIES Earnings Per Share (EPS)
[BOM: 531739]
| Y-o-Y | 7.50 % |
| 5 Yr CAGR | 28.04 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.86 | 7.50 | |
| Mar2025 | ₹0.80 | 60.00 | |
| Mar2024 | ₹0.50 | 42.86 | |
| Mar2023 | ₹0.35 | 9.37 | |
| Mar2022 | ₹0.32 | - | |
GENNEX LABORATORIES Return on Capital Employed (ROCE)
[BOM: 531739]
| Y-o-Y | -14.33 % |
| 5 Yr CAGR | -2.46 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 10.7% | -14.33 | |
| Mar2025 | 12.49% | -8.43 | |
| Mar2024 | 13.64% | 33.86 | |
| Mar2023 | 10.19% | -13.79 | |
| Mar2022 | 11.82% | - | |
GENNEX LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹8.6 |
| Current MarketCap | : | ₹ 208.7 Cr |
| Updated EOD on | : | Oct 26,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.2% |
-16.8% |
-38% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
GENNEX LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -0.9% | -7.5% | 7% |
You may also like the below Video Courses
FAQ about GENNEX LABORATORIES Financials
How the annual revenues of GENNEX LABORATORIES have changed ?
The Revenues of GENNEX LABORATORIES have increased by 59.03% YoY .
How the Earnings per Share (EPS) of GENNEX LABORATORIES have changed?
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 7.50 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs